Neuroglee Therapeutics
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
Neuroglee Therapeutics is a business in biotechnology, life science based in Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia, founded in 2020.
The company sits in the biotechnology, life science segment, where it competes on its core product or service.
The business is associated with Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia.
The company is listed at the Series_A stage of development.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $12.3M.
| Sector | Biotechnology, Life Science |
|---|---|
| Headquarters | Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $12,300,000 |
Website: neuroglee.com
Sign in to view the contact information we hold for Neuroglee Therapeutics.
Create a free account
Create a free account